These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20547302)

  • 21. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
    Chen K; Maley J; Yu PH
    J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid and amyloid-beta peptide signaling in Alzheimer's disease.
    Lukiw WJ
    World Rev Nutr Diet; 2009; 99():55-70. PubMed ID: 19136839
    [No Abstract]   [Full Text] [Related]  

  • 23. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid beta-protein and lipid metabolism.
    Zinser EG; Hartmann T; Grimm MO
    Biochim Biophys Acta; 2007 Aug; 1768(8):1991-2001. PubMed ID: 17418089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Handb Clin Neurol; 2008; 89():245-60. PubMed ID: 18631749
    [No Abstract]   [Full Text] [Related]  

  • 27. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipids on the pathomechanisms of amyloid diseases.
    Ramamoorthy A
    Chem Phys Lipids; 2021 Sep; 239():105122. PubMed ID: 34375659
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing.
    Grimm MO; Haupenthal VJ; Mett J; Stahlmann CP; Blümel T; Mylonas NT; Endres K; Grimm HS; Hartmann T
    Neurodegener Dis; 2016; 16(1-2):44-54. PubMed ID: 26642316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biochemistry study on brain pathology in Alzheimer's disease. Biochemical approach to the etiological mechanism].
    Nukina N
    Nihon Rinsho; 1988 Jul; 46(7):1475-83. PubMed ID: 3065524
    [No Abstract]   [Full Text] [Related]  

  • 32. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.
    Guillemin GJ; Brew BJ
    Redox Rep; 2002; 7(4):199-206. PubMed ID: 12396664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurobiology of isoprostanes and Alzheimer's disease.
    Praticò D
    Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linking transcription to physiology in lipidomics.
    Crestani M; Moschetta A
    Biochim Biophys Acta; 2015 Jan; 1851(1):1. PubMed ID: 25449651
    [No Abstract]   [Full Text] [Related]  

  • 35. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 36. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
    Obulesu M; Somashekhar R; Venu R
    Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of lipid metabolism in Alzheimer's disease].
    Kamino K; Tanaka T; Kida T; Ohkochi M; Tanii H; Kudo T; Takeda M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Aug; 22(4):103-10. PubMed ID: 12373863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease.
    Querfurth HW; LaFerla FM
    N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.